KRRISTA BLUE-P Advanced Dual-Action Formula​

KRRISTA BLUE-P™ – Advanced Dual-Action Formula​

Manufacturer: The Lotus Biotech (India)
​Active Ingredients:

• ​Sildenafil Citrate 110mg​ (Superior Erectile Hardness)
• ​Dapoxetine Hydrochloride 110mg​ (Extended Ejaculatory Control)
  ​Packaging: 10 tablets/blister

⚠️ ​Critical Safety Notice​

“HIGH-DOSE FORMULATION (110mg each):
• Exceeds standard ED treatment doses (typically 50-100mg Sildenafil)
• Not for first-time users or mild ED/PE cases
• Start with ½ tablet ONLY under medical supervision“

📊 ​Enhanced Therapeutic Outcomes​

💡 ​Target Users & Usage Guidance​

▶️ ​Ideal Candidates​

• ​Severe ED: Failure to achieve/maintain penetration-capable erections
• ​Chronic PE: Ejaculation <2 minutes after penetration
• ​Combined ED+PE: Comorbid cases requiring dual therapy

⛔ ​Contraindications​

• Cardiovascular disease | Nitrate users | Hepatic/renal impairment
• Mild ED/PE (use standard 50mg/60mg formulations first)

💊 ​Dosage Protocol​

1. ​Initial Dose: ​½ tablet​ (55mg Sildenafil + 55mg Dapoxetine)
2. ​Timing: 1-2 hours before sexual activity on empty stomach
3. ​Max Frequency: Once per 48 hours

“Discontinue if priapism >4 hours or severe vertigo occurs”

🔬 ​Why 110mg?​​

• ​Sildenafil 110mg: Extreme PDE5 saturation → unprecedented corporeal rigidity (“steel-like erection”)
• ​Dapoxetine 110mg: Rapid CNS serotonin modulation → 3-5x ejaculatory latency vs. standard 60mg

🌐 ​Global Market Position​

• ​First commercial 110mg dual-action tablet​
• ​Fills therapeutic gap​ for treatment-resistant ED+PE
• ​Lot-specific quality testing: HPLC purity >99.8%

⚖️ ​Comparative Analysis​

📍 ​Purchasing Advisory​

• ​Requires prescription: Telemedicine consultation mandatory
• ​Authenticity Verification: Hologram-sealed packaging with SMS code check
• ​Storage: 15-30°C in original container